Toshiba presents PowerVision 8000 at AHA

Article

Toshiba America Medical Systems unveiled a new ultrasound system at this month’s American Heart Association meeting in Atlanta. Cleared by the Food and Drug Administration, PowerVision 8000 is a 512-channel unit for cardiology configured for a range

Toshiba America Medical Systems unveiled a new ultrasound system at this month’s American Heart Association meeting in Atlanta. Cleared by the Food and Drug Administration, PowerVision 8000 is a 512-channel unit for cardiology configured for a range of clinical applications and calculation packages. Twelve transducers are available with the device, and users may purchase additional transducers to expand the system’s applications.

PowerVision 8000 features Toshiba’s work-in-progress PowerView package, a digital information management system that supports all DICOM service classes; integrated 3-D and stress echo applications software; live digital streaming for telemedicine; and a quantitative analysis package. PowerView can be used to send still frame and dynamic images to review stations or printers, access worklist interfaces to the HIS/RIS system, and retrieve exams from archives.

PowerVision 8000 has a dynamic range of 175 dB. The unit supports Toshiba’s Flash Echo Imaging technology and color harmonics package, which allows clinicians to quantify blood flow and perfusion; and Automatic Cardiac Output, which measures cardiac output and stroke volume based on color Doppler principles. PowerVision also supports Quad Signal Processing, which improves the system’s frame rate and color imaging, and True Triplex Imaging, which provides for real-time gray-scale, color, and Doppler imaging of up to 20 frames per second.

In other Toshiba ultrasound news, the Tustin, CA, company named Scott Yarde to the post of director, ultrasound marketing. Yarde joins Toshiba from Philips Medical Systems, where he served for seven years in various positions, including Southwest regional sales manager, Western zone MRI sales manager, and MRI product sales manager.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.